Results 31 to 40 of about 1,565,970 (254)
Journal of Mazandaran University of Medical Sciences, 2022 Background and purpose: Treatment of rheumatic diseases depends on proper use of medications. The aim of this study was to evaluate the frequency and reasons for discontinuation of drugs in these patients.
Maryam Mobini +2 more
doaj
Archives of Medical Science, 2019 Introduction International recommendations are intended to help rheumatologists in the effective management of rheumatoid arthritis (RA) through an evidence-based approach.
Bogdan Batko +3 more
doaj +1 more source
The problem of laboratory monitoring in therapy with disease-modifying antirheumatic drugs and biological agents in patients with rheumatoid arthritis [PDF]
, 2018 The paper discusses the problem of laboratory monitoring in therapy with disease-modifying antirheumatic drugs (DMARDs) and biological agents (BAs) in patients with rheumatoid arthritis (RA). Due to the risk of adverse reactions, in particular to that of
L. A. Muravyeva, Yu. V. Muravyev
core +1 more source
Role of biological agents in treatment of rheumatoid arthritis [PDF]
, 2019 Advances in understanding of the pathophysiology of rheumatoid arthritis with concurrent advances in protein engineering led to the development of biological disease-modifying antirheumatic drugs which have dramatically revolutionized the treatment of ...
core +1 more source
Antirheumatic drugs in older adults and polypharmacy issues
, 2021 Older individuals experience various noninflammatory and autoimmune inflammatory rheumatic diseases. Given the increased incidence of rheumatic conditions in older adults, it is of great importance for healthcare providers to be aware of the potential ...
Kutsal, Yesim Gokce +3 more
core +1 more source
Arthritis Research & Therapy, 2022 Background To analyse the subsequent clinical course of patients with rheumatoid arthritis (RA) who either continued or discontinued biologic agents after hospitalization for infections.
Yusuke Kashiwado +19 more
doaj +1 more source
[Current aspects of antirheumatic therapy in pregnancy planning, during pregnancy and breastfeeding]. [PDF]
, 2021 Active rheumatic disease is a known factor for increased fetomaternal risks during pregnancy. Remission or inactive disease should therefore be targeted to reduce these risks by using pregnancy-compatible antirheumatic drugs as recommended by ...
Häfeli, Celine +3 more
core +1 more source
Antirheumatic drugs and reproduction in women and men with chronic arthritis. [PDF]
, 2015 The impact of rheumatic disease on fertility and reproduction can be remarkable. Many disease-related factors can influence patients' sexual functioning, perturb fertility and limit family planning. Antirheumatic pharmacological treatment can also have a
ANDREOLI, Laura +4 more
core +1 more source
Journal of Rheumatic DiseasesObjective: Juvenile idiopathic arthritis (JIA) is the most common chronic arthritis in children, with an unknown cause and prolonged disease course. Biologic disease-modifying anti-rheumatic drugs (bDMARDs) have improved outcomes in severe or refractory ...
Jong Gyun Ahn +4 more
doaj +1 more source
, 2018 Supplemental Material, Table_S1 for Comparison of Serious Adverse Event Profiles Among Antirheumatic Agents Using Japanese Adverse Drug Event Report Database by Yomei Matsuoka, Mamoru Narukawa in Therapeutic Innovation & Regulatory Science
Mamoru Narukawa (5170892) +1 more
core +1 more source